v3.25.2
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)
 6 Months Ended
Jun. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The Company records all cash flow hedging instruments on the consolidated balance sheets at fair value. The fair values of outstanding derivative instruments designated as cash flow hedging instruments were as follows:
June 30,
December 31,
20252024
Unaudited
Prepaid expenses and other current assets$2,788 $468 
Accrued expenses and other current liabilities$(20)$(50)
Schedule of Derivative Instruments, Gain (Loss)
The gains (losses) related to cash flow hedging instruments, recorded in the consolidated interim statements of loss, for the three and six months ended June 30, 2025 and 2024, were as follows:
Three months ended June 30,Six months ended
June 30,
2025202420252024
Unaudited
Cost of revenues$66 $— $82 $15 
Research and development577 — 725 174 
Sales and marketing150 — 188 43 
General and administrative108 — 135 35 
Total gains recognized in the consolidated statements of loss, net$901 $— $1,130 $267 
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)
The changes in unrealized gains (losses) on the Company’s derivative instruments recorded in accumulated other comprehensive income (loss) were as follows:
Six months ended
June 30,
20252024
Unaudited
Unrealized gains on derivative instruments at the beginning of the period$418 $948 
Changes in fair value of derivative instruments3,480 (720)
Reclassification of gains recognized in the consolidated interim statements of loss from accumulated other comprehensive income (loss)(1,130)(267)
Unrealized gains (losses) on derivative instruments at the end of the period (unaudited)$2,768 $(39)